Wednesday, June, 26, 2019 06:56:50

Category: Health

GeoVax & Enesi team up to develop vaccines administered by ImplaVax®

The biotechnology company GeoVax Labs, Inc. has reportedly announced to have joined hands with the pharmaceutical firm Enesi Pharma to develop needle-free solid-dose vaccine formulations by using its unique Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform along with Enesi’s ImplaVax® device and formulation technology. …

Myriad Genetics announces the publication of Vectra(R) clinical study

The outcome of the Vectra(R) clinical studies were published in the journal Rheumatology. The adjusted Vectra(R) test is significantly more effective than conventional methods in predicting radiographic progression in individuals suffering from Rheumatoid Arthritis. Myriad Genetics, Inc. (Myriad), a leading American molecular diagnostic firm, has …

Glenmark Pharma ventures into the U.S. branded dermatology sector

Glenmark’s branded portfolio will be developed and commercialized under the subsidiary Glenmark Therapeutics Inc., USA. Renowned pharmaceutical firm, Glenmark Pharmaceuticals has recently announced that its wholly owned subsidiary, Glenmark Therapeutics Inc., USA, will enter the branded dermatology segment in the United States. This will be …

Staten & Novo Nordisk partner to develop dyslipidaemia treatment

Forbion, a healthcare venture capital firm with centers in Germany and the Netherlands, recently announced that its portfolio company Staten Biotechnology B.V. and Denmark-based healthcare company Novo Nordisk A/S have collaborated and signed an exclusive option agreement in a bid to develop new therapeutics hypertriglyceridaemia …